Bio-Rad (BIO) Down 6.9% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 08/29/20
Bio-Rad Laboratories: Poor ROCE Of 3% Hurts Valuation, But The Long-Term Stance RemainsSeeking Alpha • 08/19/20
The United States Court of Appeals for the Federal Circuit Affirms That 10x Genomics Willfully Infringed Bio-Rad U.S. Patent and Upholds Lower Court’s Award of DamagesBusiness Wire • 08/04/20
Bio-Rad Laboratories (BIO) Q2 Earnings and Revenues Surpass EstimatesZacks Investment Research • 07/30/20
Bio-Rad to Report Second-Quarter 2020 Financial Results, Thursday, July 30, 2020Business Wire • 07/16/20
Bio-Rad: A Very Interesting Short-Term Investment Thanks To Gains On Sartorius HoldingSeeking Alpha • 05/29/20
Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/07/20
Bio-Rad Laboratories (BIO) Q1 Earnings and Revenues Surpass EstimatesZacks Investment Research • 05/07/20
Earnings Preview: Bio-Rad Laboratories (BIO) Q1 Earnings Expected to DeclineZacks Investment Research • 04/29/20